March 26, 2018 / 11:51 AM / 4 months ago

BRIEF-Lexicon Announces Regulatory Submissions For Sotagliflozin To Treat Adults With Type 1 Diabetes

March 26 (Reuters) - Lexicon Pharmaceuticals Inc:

* LEXICON PHARMACEUTICALS ANNOUNCES REGULATORY SUBMISSIONS FOR SOTAGLIFLOZIN TO TREAT ADULTS WITH TYPE 1 DIABETES

* LEXICON PHARMA - SANOFI SUBMITTED NDA TO FDA FOR SOTAGLIFLOZIN COMBINED WITH INSULIN THERAPY TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 1 DIABETES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below